Zeto Inc continued to build visibility this week as its point-of-care EEG technology was featured in the Season 2 finale of HBO Max medical drama The Pitt. The episode portrays a high-acuity obstetric emergency where clinicians rely on rapid, bedside, full-montage EEG to stabilize a deteriorating patient, underscoring the importance of real-time brain monitoring.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Across posts highlighting the cameo, Zeto emphasized persistent clinical challenges such as delays in EEG access and the need to transfer patients solely to obtain monitoring. By presenting its system as a solution that brings EEG directly to the bedside when minutes matter, the company is reinforcing its positioning in emergency, intensive-care, and other critical-care environments.
This week’s media exposure follows Zeto’s recent showcase at the American Academy of Neurology Annual Meeting 2026, where it highlighted its Zeto ONE hospital platform, newly FDA-cleared New Wave EEG system for clinics, and NeuroNotis AI seizure-detection reporting tool. Live demonstrations and participation in a teleneurology workshop led by Massachusetts General Hospital neurologists further underscored the role of Zeto’s platform in both in-person and virtual neurology workflows.
Taken together, the combination of clinical conference engagement and mainstream media placement is enhancing Zeto’s brand recognition among clinicians and hospital decision-makers. While the TV appearance is not a formal clinical endorsement, it supports awareness of point-of-care EEG in high-acuity settings and may strengthen the company’s competitive stance and commercial prospects in neurodiagnostics and teleneurology over time.